We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Anti-Human p75 pAb

Antibody Specific for the p75 Neurotrophin Receptor (p75NTR)

  • Purified rabbit IgG produced against the cytoplasmic domain of the human p75 neurotrophin receptor
  • Reacts with human, rat, mouse and chicken p75
  • Antibody supplied as 1mg/ml in PBS containing 50μg/ml gentamicin

Size

Catalog number selected: G3231

$ 445.00 Your price: Log In

Add to Helix
Anti-Human p75 pAb
200μg
$ 445.00
Your price: Log In

The p75 neurotrophin receptor (p75NTR), also known as low-affinity NGF receptor (LNGFR) and p75LNGFR, binds nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4 with varying specificities. p75NTR plays an important role in neurotrophic factor signaling including neuronal apoptosis. Anti-Human p75 pAb provides a valuable tool for understanding the role of p75NTR in neuronal death. Anti-Human p75 pAb is raised against a recombinant fusion protein produced in E. coli.

Applications (suggested working concentration)

  • Immunocytochemistry (1–10μg/ml).
  • Immunohistochemistry (1–10μg/ml).
  • Immunoprecipitation (1–10μg/ml).

Note: This antibody is not recommended for use in Western blot analysis due to potential for cross-reactivity with the fusion tag on the immunogen.

Specifications

What's in the box?

Item Part # Size

Anti-Human p75 pAb

G323A 1 x 200μg

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

Resources

Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom